Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -30.77MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 0.72Close
$ 0.65 - $ 3.05 52-Week Range
Ticker Information
Ticker
TVGNCompany Name
TEVOGEN BIO HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTEVOGEN BIO HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TVGN - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 601.47K | $ -31.37M | $ -30.77M |
| 3/31/2025 | $ 410.68K | $ -31.85M | $ -31.43M |
| 12/31/2024 | $ 403.58K | $ -10.09M | $ -9.69M |
| 9/30/2024 | $ 400.9K | $ -4.62M | $ -4.22M |
| 6/30/2024 | $ 576.65K | $ -55.72M | $ -55.15M |
| 3/31/2024 | $ 476.66K | $ -49.84M | $ -49.37M |
| 12/31/2023 | $ 378.36K | $ -59.27M | $ -58.89M |
| 9/30/2023 | $ 0 | $ 3.38M | $ 3.38M |
| 6/30/2023 | $ 0 | $ 5.27M | $ 5.27M |
| 3/31/2023 | $ 0 | $ 5.67M | $ 5.67M |
Key Performance Insights, Last 5 Years
- TEVOGEN BIO HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -28.75K.
- Over the past 5 years, TEVOGEN BIO HOLDINGS INC's average EBITDA has been $ -16.97M.
- The median EBITDA for TEVOGEN BIO HOLDINGS INC during this period was $ -4.22M
- TEVOGEN BIO HOLDINGS INC reached its highest EBITDA over the past 5 years at $ 5.67M.
- The lowest EBITDA recorded by TEVOGEN BIO HOLDINGS INC in the same timeframe $ -58.89M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for TEVOGEN BIO HOLDINGS INC is calculated as follows: EBIT [ $ -28.75K ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -28.75K ] TVGN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -58.89M
Minimum
Dec 31, 2023
$ 5.67M
Maximum
Mar 31, 2023
$ -16.97M
Average
$ -4.22M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.8M with a standard deviation of $ 166.97M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.8M |
| median | $ 8.83M |
| std | $ 166.97M |